X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/02/03/2601208/0/en/Regulatory-filing-for-house-dust-mite-allergy-tablet-accepted-for-review-in-China.html
https://www.globenewswire.com/news-release/2023/02/03/2601160/0/en/Annual-report-2022-ALK-delivers-sales-growth-of-13-with-profits-up-33-in-2022.html
https://www.globenewswire.com/news-release/2022/12/19/2576524/0/en/ALK-Financial-calendar-for-the-2023-financial-year.html
https://www.globenewswire.com/news-release/2022/07/03/2473202/0/en/ALK-spotlights-the-impact-of-respiratory-allergies-on-children-at-EAACI-Congress.html
https://www.globenewswire.com/news-release/2022/06/27/2469318/0/en/ALK-begins-clinical-trial-of-its-SLIT-tablet-for-the-treatment-of-peanut-allergy.html
https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-ubs-global-healthcare-conference-301550900.html
https://www.globenewswire.com/news-release/2022/03/03/2396063/0/en/Clinical-trial-waiver-in-China-opens-door-to-2022-registration-filing-for-ALK-s-dust-mite-allergy-tablet.html
http://www.fiercebiotech.com/biotech/merck-shocks-alk-by-returning-rights-to-allergy-immunotherapies
http://www.in-pharmatechnologist.com/Regulatory-Safety/US-FDA-finds-cGMP-deviations-at-ALK-Abello-facility-in-Denmark
Market Place
Share 
